Anis Ahmadi, MD
Gastroenterology · Saint Augustine, FLNPI 1932270832
Payments from drug & device makers
Across 409 payments — averaging $88.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shire North American Group Inc$29K
- AbbVie$2K
- Takeda Pharmaceuticals U.S.A., Inc.$601
- Johnson & Johnson$598
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$481
- Madrigal Pharmaceuticals$449
- plus $3K from 28 others
What the payments were for
- Food & beverage$6,90999%
- Education$911%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shire North American Group Inc | 18 | $29,203 |
| AbbVie | 141 | $2,213 |
| Takeda Pharmaceuticals U.S.A., Inc. | 36 | $601 |
| Johnson & Johnson | 36 | $598 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 29 | $481 |
| Madrigal Pharmaceuticals | 19 | $449 |
| QOL Medical, LLC | 11 | $248 |
| Sanofi | 11 | $242 |
| Bristol Myers Squibb | 14 | $240 |
| Regeneron Healthcare Solutions, Inc. | 10 | $200 |
| Gilead | 10 | $192 |
| Lilly USA, LLC | 10 | $188 |
| Merck | 11 | $186 |
| Braintree Laboratories, Inc. | 7 | $132 |
| Medtronic | 1 | $122 |
| Ironwood Pharmaceuticals, Inc | 6 | $102 |
| Phathom Pharmaceuticals, Inc. | 5 | $101 |
| E.r. Squibb & Sons, L.L.C. | 1 | $85 |
| Pfizer | 5 | $74 |
| Alnylam Pharmaceuticals Inc. | 3 | $72 |
| Enterra Medical, Inc. | 3 | $68 |
| Aimmune Therapeutics, Inc. | 4 | $63 |
| Daiichi Sankyo Inc. | 4 | $61 |
| Evoke Pharma, Inc. | 1 | $42 |
| Ipsen Biopharmaceuticals, Inc | 2 | $40 |
| Redhill Biopharma Inc. | 2 | $36 |
| Intercept Pharmaceuticals, Inc. | 2 | $34 |
| Celltrion USA Inc. | 1 | $24 |
| Pentax Of America, Inc. | 1 | $20 |
| Pharmacosmos Therapeutics Inc. | 1 | $20 |
| Vivus LLC | 1 | $19 |
| Shionogi Inc | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
| Alfasigma USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$36,203 in reported general payments places this provider in the 85th percentile of 1,388 gastroenterology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 49 | $32,728 |
| CreonLipase/Protease/Amylase | 13 | $31,515 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 242 | $14,856 |
| MovantikNaloxegol Oxalate | 30 | $11,934 |
| Mesalamine ErMesalamine | 24 | $9,149 |
| Pantoprazole Sodium | 312 | $3,889 |
| Omeprazole | 277 | $3,580 |
| Balsalazide Disodium | 17 | $3,203 |
| Ursodiol | 11 | $2,577 |
| CholestyramineCholestyramine (With Sugar) | 30 | $2,227 |
| Famotidine | 126 | $2,080 |
| Colestipol Hcl | 36 | $1,719 |
| Sucralfate | 42 | $1,391 |
| Dicyclomine Hcl | 45 | $823 |
| Esomeprazole Magnesium | 18 | $760 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess, Creon | $2,213 | $64,24362 claims |
| Redhill Biopharma Inc.Movantik | $36 | $11,93430 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,388 gastroenterology providers in Florida.
Other gastroenterology in Saint Augustine
- Howard SchwartzTavernier$38.8M
- Guy NeffSarasota$17.6M
- Syed LateefClermont$6.4M
- Jeffrey SchneiderCoral Springs$6M
- Zaid RanaMiami$5.4M
- David NelsonGainesville$5.2M
- Alan WeintraubTampa$4.7M
- Curtis FreedlandNew Port Richey$4.5M
- Paul HellsternCrystal River$4.5M
- Henry LevineOrlando$3.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.